As the country set a record high for daily COVID-19 cases this week, new treatments like the Pfizer and Merck pills that help people avoid hospitalization couldn't come at a better time. For many, the approval of the new ...
Jan 3, 2022
0
17
Newly infected COVID-19 patients have two new treatment options that can be taken at home.
Dec 26, 2021
0
52
Pulmonary embolisms are dangerous, lung-clogging blot clots. In a pilot study, scientists at the Icahn School of Medicine at Mount Sinai have shown for the first time that artificial intelligence (AI) algorithms can detect ...
Dec 21, 2021
0
2
Results from the largest clinical trial of its kind do not support the use of fish oil supplements—a source of omega-3 fatty acid—to help prevent depression. The findings are published in JAMA by a team led by investigators ...
Dec 21, 2021
0
202
China's drug authority has granted emergency approval for the country's first specialised treatment against COVID-19, found in clinical trials to significantly reduce hospitalisations and deaths among high-risk patients.
Dec 9, 2021
0
2
After a year of vaccines aimed at preventing COVID, treatments for people infected with the virus are few, with most restricted to hospital use and extremely pricey.
Dec 3, 2021
0
1
Almost two-thirds of U.S. states failed to prioritize cancer patients for COVID-19 vaccinations, despite recommendations from the Centers for Disease Control and Prevention (CDC), according to a study being presented today ...
Dec 2, 2021
0
1
People with type 2 diabetes who contract COVID-19 are nearly 50% more likely to wind up in intensive care if they have poorly managed their blood sugar levels over the long-term than those with better long-term glycemic control, ...
Nov 18, 2021
0
22
Clinicians are missing opportunities to vaccinate Medicare patients against influenza, despite widespread availability of vaccines and no copayment for patients. In addition, disparities persist in vaccination uptake based ...
Nov 15, 2021
0
1
(HealthDay)—Sotrovimab reduces the risk for disease progression in high-risk patients with mild-to-moderate COVID-19, according to a study published online Oct. 27 in the New England Journal of Medicine.
Oct 29, 2021
0
6
